[HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma]
- PMID: 12850765
[HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma]
Abstract
Highly active antiretroviral therapy (HAART) has changed the epidemiology of Kaposi's sarcoma (KS) and lymphoma occurring in people living with HIV. The KS's decrease was observed early after HAART availability: although delayed, the decrease of non Hodgkin lymphoma has been sign. The improvement of immune status due to HAART has decreased the occurrence of chemotherapy triggered opportunistic infections, and survival rates have been improved. The administration of chemotherapy with HAART does not seem to increase toxicity.
Copyright John Libbey Eurotext 2003.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical